PATENT CLAIM ANALYSIS

Application Number: 15960759
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "264110"]

Abstract:
Novel azaquinazoline carboxamide derivatives of formula (I) wherein W 1 , W 2 , W 3 , W 4 , R 1 , R 2 , R 3  and m which are defined above, are p70S6K inhibitor, and can be employed, inter alia, for the treatment of hyperproliferative disorders.

Claim (Index 10):
The compound according to  claim 5 , wherein R 3  is H,

Metadata:
- Claim Count in Document: 13.0
- Percentile: 91.0
- Lexical Diversity: 1.55556
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15227638', '14432618', '14432316', '14105974', '15277479']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8188173754963886
- 35 USC 102 Novelty (BERT): 0.5680800212891094
- Combined Prediction Score: 0.7937436400756607
- Mean Citation Score: 365.420782
- Max Citation Score: 434.38058
- Similarity Product: 427.8719975664103

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test